Terms: = Ovarian cancer AND CEACAM5, CEA AND Staging
24 results:
1. Pretreatment carcinoembryonic antigen combined with cancer antigen-125 for predicting lymph node metastasis in endometrial carcinoma: a retrospective cohort study.
Huang SY; Fu HC; Wu CH; Wang SC; Ou YC; Tsai CC; Chen YY; Huang SW; Wang YW; Lin H
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11807-11813. PubMed ID: 37405474
[TBL] [Abstract] [Full Text] [Related]
2. Phase II Study of Preoperative Chemoradiotherapy With S-1 Plus Oxaliplatin for Locally Advanced Rectal cancer (PerSeUS-RC01).
Matsuhashi N; Takahashi T; Tanaka C; Yawata K; Yamada M; Iwata Y; Kiyama S; Mizutani C; Tajima JY; Ishihara T; Yoshida K
Anticancer Res; 2021 Dec; 41(12):6247-6257. PubMed ID: 34848480
[TBL] [Abstract] [Full Text] [Related]
3. Past, Present, and Future of Serum Tumor Markers in Management of ovarian cancer: A Guide for the Radiologist.
Rao S; Smith DA; Guler E; Kikano EG; Rajdev MA; Yoest JM; Ramaiya NH; Tirumani SH
Radiographics; 2021 Oct; 41(6):1839-1856. PubMed ID: 34597221
[TBL] [Abstract] [Full Text] [Related]
4. Stage III disease of ovarian, tubal and peritoneal cancers can be accurately diagnosed with pre-operative CT. Japan Clinical Oncology Group Study JCOG0602.
Onda T; Tanaka YO; Kitai S; Manabe T; Ishikawa M; Hasumi Y; Miyamoto K; Ogawa G; Satoh T; Saito T; Kasamatsu T; Nakanishi T;
Jpn J Clin Oncol; 2021 Feb; 51(2):205-212. PubMed ID: 33556170
[TBL] [Abstract] [Full Text] [Related]
5. Institutional results of Oncoovarian Dx - a novel algorithm for the preoperative evaluation of adnexal masses.
Kubelac P; Craciun A; Jalba O; Gheorghe S; Lazar G; Ignat F; Lisencu C; Rancea A; Vlad C; Irimie A; Achimas Cadariu P
J BUON; 2020; 25(3):1658-1663. PubMed ID: 32862619
[TBL] [Abstract] [Full Text] [Related]
6. Guideline No. 403: Initial Investigation and Management of Adnexal Masses.
Salvador S; Scott S; Glanc P; Eiriksson L; Jang JH; Sebastianelli A; Dean E
J Obstet Gynaecol Can; 2020 Aug; 42(8):1021-1029.e3. PubMed ID: 32736853
[TBL] [Abstract] [Full Text] [Related]
7. Fertility and Endocrine Preservation in the Management of Colorectal cancer in Women.
Chae-Kim J; Hayslip CC
Dis Colon Rectum; 2020 Jun; 63(6):723-726. PubMed ID: 32384402
[TBL] [Abstract] [Full Text] [Related]
8. ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
Castro BGR; Souza CP; Andrade CEMDC; Vieira MA; Andrade DAP; Reis RD
Rev Bras Ginecol Obstet; 2019 Jul; 41(7):440-448. PubMed ID: 31344718
[TBL] [Abstract] [Full Text] [Related]
9. Morphological, imaging and surgical aspects in endometrial endometrioid adenocarcinoma.
Berceanu C; Stepan AE; MehedinŢu C; Cîrstoiu MM; Ciortea R; Berceanu S; Gheonea IA; Brătilă E
Rom J Morphol Embryol; 2016; 57(3):995-1002. PubMed ID: 28002515
[TBL] [Abstract] [Full Text] [Related]
10. Leiomyoma of broad ligament mimicking ovarian malignancy- report of a unique case.
Mallick D; Saha M; Chakrabarti S; Chakraborty J
Kathmandu Univ Med J (KUMJ); 2014; 12(47):219-21. PubMed ID: 25855117
[TBL] [Abstract] [Full Text] [Related]
11. Primary peritoneal serous papillary carcinoma: a clinical and pathological study.
Liu Q; Lin JX; Shi QL; Wu B; Ma HH; Sun GQ
Pathol Oncol Res; 2011 Sep; 17(3):713-9. PubMed ID: 21647781
[TBL] [Abstract] [Full Text] [Related]
12. Impact of serum tumor marker determination on the management of women with borderline ovarian tumors: multivariate analysis of a French multicentre study.
Poncelet C; Fauvet R; Yazbeck C; Coutant C; Darai E
Eur J Surg Oncol; 2010 Nov; 36(11):1066-72. PubMed ID: 20817462
[TBL] [Abstract] [Full Text] [Related]
13. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary.
Virk R; Lu D
Pathol Res Pract; 2010 Jul; 206(7):489-92. PubMed ID: 19674851
[TBL] [Abstract] [Full Text] [Related]
14. [Adnexal masses management: a prospective multicentric observational study].
Huchon C; Bats AS; Bensaïd C; Junger M; Nos C; Chatellier G; Lécuru F
Gynecol Obstet Fertil; 2008 Nov; 36(11):1084-90. PubMed ID: 18964176
[TBL] [Abstract] [Full Text] [Related]
15. Retrospective multicenter study of a clinicopathologic analysis of pseudomyxoma peritonei associated with ovarian tumors (KGOG 3005).
Lee JK; Song SH; Kim I; Lee KH; Kim BG; Kim JW; Kim YT; Park SY; Cha MS; Kang SB
Int J Gynecol Cancer; 2008; 18(5):916-20. PubMed ID: 18248391
[TBL] [Abstract] [Full Text] [Related]
16. Primary appendiceal cancer: gynecologic manifestations and treatment options.
Dietrich CS; Desimone CP; Modesitt SC; Depriest PD; Ueland FR; Pavlik EJ; Kryscio R; Cibull M; Huh W; Partridge E; Numnum TM; Schilder J; Higgins RV; van Nagell JR
Gynecol Oncol; 2007 Mar; 104(3):602-6. PubMed ID: 17055559
[TBL] [Abstract] [Full Text] [Related]
17. [ovarian and para-aortic recurrence from cervix cancer detected by PET/CT].
Ubieto MA; Paredes P; Martínez S; Ortín J; Fuster D; Torné A; Setoain FJ; Pahisa J; Pons F; Lomeña F
Rev Esp Med Nucl; 2006; 25(1):31-4. PubMed ID: 16540009
[TBL] [Abstract] [Full Text] [Related]
18. [Combined use of tumor markers and MRI tomography in differential diagnosis of ovarian neoplasms].
Pavlov SB; Akulina EA; Pavlova GB
Klin Med (Mosk); 1999; 77(4):49-51. PubMed ID: 10356919
[TBL] [Abstract] [Full Text] [Related]
19. OVX1 and cea in patients with colon carcinoma, colon polyps and benign colon disorders.
Martell RE; Xu FJ; Davis WZ; Anselmino L; Yu YH; Daly L; Bast RC
Int J Biol Markers; 1998; 13(3):145-9. PubMed ID: 10079388
[TBL] [Abstract] [Full Text] [Related]
20. Role of In-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma.
Markowitz A; Saleemi K; Freeman LM
Clin Nucl Med; 1993 Aug; 18(8):685-700. PubMed ID: 8403703
[TBL] [Abstract] [Full Text] [Related]
[Next]
